Clinical Advisor
Research & Development
MiNA therapeutics
United Kingdom
Antonin held several senior R&D leadership roles including Chief Scientific Officer of Moderna Therapeutics, Chief Scientific Officer of Tolerx and Vice President, Research, Immunology, Metabolic, and Viral Disease at Alnylam Pharmaceuticals. After completing his PhD in Immunology at Harvard University, Antonin was a research fellow at the Wellcome Trust Immunology Unit, University of Cambridge.
Immunology